At-Home Drug of Abuse (DOA) Testing Market 2024 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2030

Page: 215 | Report Code: LS240311 | Research Suite: Report (PDF) & Market Data (Excel)

NOTE: Due to exhaustive nature of content, full ToC can't be uploaded. Please request Sample Pages to receive full table of content. 

At-home drug of abuse (DOA) testing refers to the process of conducting drug screening tests at a convenience of one's home or one's personal environment these tests are designed to detect the presence of illicit drugs or prescription medications in biological samples such as urine, saliva or blood collected in collectible materials (cups or oral swabs) and test strips or cartridges that indicate the presence of specific drugs through color changes or digital readout. DOA testing offers individuals a quick and confidential way to screen for drug use without the need for laboratory analysis and testing kits are available for a wide range of substances.

MARKET OVERVIEW

The global market valuation of At-Home Drug of Abuse (DOA) Testing market was valued at approximately USD 3.5 billion in 2022 and is projected to reach USD 7.2 billion by 2030 exhibiting a CAGR of 7%, these testing kits provides privacy and convenience moreover with rapid results which allows the individuals to take proactive tests towards substance abuse and treatment plans accordingly is driving the growth of the market.

GROWTH DRIVERS

The convenience factor has led to the increased adoption, especially among parents monitoring their children or individuals testing themselves directly at their own comfort level in a private space is one of a significant driver the market. The growing awareness and rising substance use of recreational drugs and risk associated with substance abuse has led to a greater demand for at home drug testing kits among individuals to detect and address to monitor drug use and promote accountability.

The growing trend of telehealth and telemedicine services has increased access to recommendation of at-home drug testing kits by the health professionals is contributing to the growth of the market. The growing percentage on preventative health measures and self-care has caused individuals to take proactive steps to monitor their health and moreover the easy availability of the products on e-commerce or online pharmacies has made DOA kits very easily accessible to a broader consumer worldwide.

MARKET SEGMENTATION:

·         By Type – test cup, test strips and others

·         By Sample – saliva, blood, urine and others

·         By Region - North America, Europe, Asia Pacific, the Middle East and Africa, and South America.

At-Home Drug of Abuse (DOA) Testing Market by Type Segment Review:

The test cups are also all in one drug testing kits because it includes integrated testing panels that are used to screen various illicit substances, specimen collection cups which eliminates the need for additional sample containers and for collecting urine samples directly with a secure lid to provide leakage and result indicators that are used for detection of drugs simultaneously and these testing cups offers convenience and ease of use, making it popular among individuals and families for conducting drug tests at home and often preferred for their simplicity and accuracy in detecting multiple drug classes simultaneously. The test strips are thin paper like strips coated with chemical reagents that react with specific drugs or their metabolites in urine simple and the color changing interprets the results, basically the user dips the strip into the urine sample collected and observes the change in color of the strip which demonstrates the result accordingly, test trips are portable and provide quick results which makes it a convenient option for at-home drug testing.

At-Home Drug of Abuse (DOA) Testing Market by Sample Segment Review:

The saliva drug testing kits are noninvasive in nature and are very easy to use, basically these kits involves collection of saliva as a sample collected by using a swab or collection device and further analyzing the saliva sample for the presence of drugs or their metabolites. It is very quick in providing results and can detect recent drug use which makes it suitable for the on-the-spot testing or monitoring drug use in real time. Urine based drug testing is one of the most common methods used for at home drug testing in which the user has to collect a urine sample provided in a testing cup or container and then the user has to use a test strip analyze the urine sample for the drug presence in it, during, urine drug test is easy to administer by the user and can detect a wide range of drugs and it is suitable for both recent and past drug use, making it a versatile option for various testing methods. Blood based drug testings are not commonly used as compared to saliva based or urine-based drug testing due to invasive nature of collection of blood sample usually the sample is collected from the fingertips and applied on the testing device and further analyzed, blood test can detect drugs at lower concentrations and it provides more precise results compared to saliva and urine based tests.

At-Home Drug of Abuse (DOA) Testing Market by Regional Analysis:

North America leads the global market due to the high prevalence of drug use and presence of key global companies like Abbott laboratories which offers a wide range of at home drug testing kits. Europe is a significant market driven by increasing initiatives to combat drug abuse and the European Union initiatives like “EU Drugs strategy 2021-2025". The Pacific region represents significant growth opportunities fueled by increasing awareness about drug abuse prevention and big influence of ecommerce and online pharmacies. The Middle Africa is witnessing market growth due to improving healthcare infrastructure and raising awareness about such abuse. South America shows promising growth prospects driven by increasing drug abuse rates and growing healthcare expenditure and the growth of ecommerce platforms.

Key Challenges:

The accuracy and reliability of a home drug of at home drug testing kits poses a significant challenge because the variability in testing methodology and sample collection techniques may lead to false positives or false negatives which leads to false treatment plans, collecting samples such as urine or saliva accurately at home may be challenging for users which further may compromise the integrity of the test results, like inadequate sample collection may affect the detection of drug. Most of the at home drug testing kits offer limited panels which is for only specific drugs or class of drugs and that leads to the inability to test for a comprehensive range of substances.

Competitive Landscape:

The leading companies investing in research and development to continuously innovate by adding more parameters for accuracy or including more detection of drugs and improve the testing kits and develop user friendly and more reliable testing solutions. The leading companies are providing educational resources, awareness campaigns and training programs for consumers and healthcare professionals to enhance product knowledge and how to properly use their company testing kits which is also indirectly helping in marketing and advertising of their company products. The leading companies are forming strategic partnerships with pharmacies and retail chains and online pharmacies to expand the market reach and product accessibility and offering the product at competitive pricing and affordability for attracting price sensitive consumers and capture market share to maintain the competitiveness in the market.

Global Key Players:

·         Abbott

·         Drager AG

·         Hangzhou

·         Atlas

·         BioSciences

·         Siemens

·         Thermo Fisher

·         Roche

·         Bio-Rad

·         OraSure

  

Attributes

Details

Base Year

2022

Trend Period

2023 – 2030

Forecast Period

2023 – 2030

Pages

215

By Type

Test cup, test strips and others

By Sample

Blood, Urine, saliva and others

By region

North America, Europe, Asia Pacific, the Middle East and Africa, and South America

Company Profiles

Abbott, Drager AG, Hangzhou, Atlas, BioSciences, Siemens, Thermo Fisher, Roche, Bio-Rad, OraSure

Edition

1st edition

Publication

Feb 2024

Buy Report

  • $1990
  • $2990